Joe McCann is the founder of Point Biopharma. Point Biopharma has raised $650M in total funding. Latest round: IPO. Based in Indianapolis, IN.
Joe McCann is the CEO of Point Biopharma. He guided the company through asset development, managed in- and out-licensing deals, and raised over $650 million. He took Point Biopharma public on NASDAQ in July 2021 via a SPAC merger. In October 2023, Eli Lilly and Company acquired Point Biopharma Global Inc. for approximately $1.4 billion.
Full founder directory · Investor directory · Company funding database · Fundraising library